Skip to content

Drug interactions

Canagliflozin-metformin + Nilotinib

Severity: Moderate

Canagliflozin-metformin and Nilotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib is associated with hyperglycemia in some patients, which may reduce the effectiveness of antidiabetic therapy. Glucose elevations are generally manageable.

What this interaction means in plain words

Canagliflozin-metformin and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Canagliflozin-metformin belongs to Endocrine; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Nilotinib has an independent hyperglycemic effect whose mechanism is not fully established.

What to do

Monitor blood glucose during nilotinib therapy and intensify the antidiabetic regimen if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin-metformin and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Canagliflozin-metformin with Nilotinib?

MediHelp rates the interaction as moderate. Canagliflozin-metformin and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nilotinib is associated with hyperglycemia in some patients, which may reduce the effectiveness of antidiabetic therapy. Glucose elevations are generally manageable.

How serious is the interaction between Canagliflozin-metformin and Nilotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose during nilotinib therapy and intensify the antidiabetic regimen if needed.

What other medicines interact with Canagliflozin-metformin?

MediHelp also lists interactions of Canagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Canagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in